Literature DB >> 32394012

Risk Factors and Outcome of Portal Vein Thrombosis After Laparoscopic and Open Hepatectomy for Primary Liver Cancer: A Single-Center Experience.

Akira Mori1, Akira Arimoto2, Yuhei Hamaguchi2, Masatoshi Kajiwara2, Akio Nakajima2, Seiichiro Kanaya2.   

Abstract

BACKGROUND: Post-hepatectomy portal vein thrombosis (PH-PVT) is a severe complication. The risk factors of PH-PVT after laparoscopic and open hepatectomy have not been clarified yet. We aimed to retrospectively investigate the risk factors and outcome of PH-PVT in patients with primary liver cancer.
METHODS: We enrolled 622 consecutive patients who underwent hepatectomy in our hospital between January 2006 and August 2016.
RESULTS: Of 21 patients (3.4%) with PH-PVT, 7 had grade I; 13, grade II; and 1, grade III. The patients with PH-PVT were significantly older than those without PH-PVT. Of the 413 patients who underwent open hepatectomy, those who underwent a major right hepatectomy (4.1%) had a slightly higher incidence of PH-PVT. Of the 209 patients who underwent laparoscopic hepatectomy, those who underwent a left lateral sectionectomy (21.2%) and major right hepatectomy (16.7%) had high incidence rates of PH-PVT. The treatment was only observation in five patients, medication with an antithrombotic drug in 15 patients, and reoperation in one patient. PH-PVT diminished in 17 patients. Cavernous transformation and/or stenosis of the portal vein developed in three patients. The patient with grade III PH-PVT after open right hemihepatectomy underwent reoperation but died of hepatic failure.
CONCLUSION: This study demonstrated that patient age, left lateral sectionectomy were risk factors of PH-PVT. Laparoscopic left lateral sectionectomy and major right hepatectomy might bring about relatively higher risk of PH-PVT. Major right hepatectomy tends to lead to severe PH-PVT. Careful handling of the PV during hepatectomy and early treatment of PH-PVT are necessary.

Entities:  

Mesh:

Year:  2020        PMID: 32394012     DOI: 10.1007/s00268-020-05565-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

1.  Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka.

Authors:  Go Wakabayashi; Daniel Cherqui; David A Geller; Joseph F Buell; Hironori Kaneko; Ho Seong Han; Horacio Asbun; Nicholas OʼRourke; Minoru Tanabe; Alan J Koffron; Allan Tsung; Olivier Soubrane; Marcel Autran Machado; Brice Gayet; Roberto I Troisi; Patrick Pessaux; Ronald M Van Dam; Olivier Scatton; Mohammad Abu Hilal; Giulio Belli; Choon Hyuck David Kwon; Bjørn Edwin; Gi Hong Choi; Luca Antonio Aldrighetti; Xiujun Cai; Sean Cleary; Kuo-Hsin Chen; Michael R Schön; Atsushi Sugioka; Chung-Ngai Tang; Paulo Herman; Juan Pekolj; Xiao-Ping Chen; Ibrahim Dagher; William Jarnagin; Masakazu Yamamoto; Russell Strong; Palepu Jagannath; Chung-Mau Lo; Pierre-Alain Clavien; Norihiro Kokudo; Jeffrey Barkun; Steven M Strasberg
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

Review 2.  Novel classification of non-malignant portal vein thrombosis: A guide to surgical decision-making during liver transplantation.

Authors:  Prashant Bhangui; Chetana Lim; Eric Levesque; Chady Salloum; Eylon Lahat; Cyrille Feray; Daniel Azoulay
Journal:  J Hepatol       Date:  2019-08-20       Impact factor: 25.083

3.  Extensive Thrombectomy as a Legitimate Strategy in Living Donor Liver Transplantation With Advanced Portal Vein Thrombosis.

Authors:  Toru Ikegami; Tomoharu Yoshizumi; Yuriko Tsutsui; Noboru Harada; Shinji Itoh; Shohei Yoshiya; Daisuke Imai; Hideaki Uchiyama; Masaki Mori
Journal:  Liver Transpl       Date:  2019-09-20       Impact factor: 5.799

4.  Critical Appraisal of the Impact of the Systematic Adoption of Advanced Minimally Invasive Hepatobiliary and Pancreatic Surgery on the Surgical Management of Mirizzi Syndrome.

Authors:  Ye-Xin Koh; Pallavi Basu; Yi-Xin Liew; Jin-Yao Teo; Juinn-Huar Kam; Ser-Yee Lee; Peng-Chung Cheow; Premaraj Jeyaraj; Pierce K H Chow; Alexander Y F Chung; London L P J Ooi; Chung-Yip Chan; Brian K P Goh
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

  4 in total
  5 in total

1.  Prospective validation to prevent symptomatic portal vein thrombosis after liver resection.

Authors:  Nao Yoshida; Shintaro Yamazaki; Moriguchi Masamichi; Yukiyasu Okamura; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2022-05-27

2.  New classification-oriented treatment strategy for portal vein thrombosis after hepatectomy.

Authors:  Shinji Onda; Kenei Furukawa; Yoshihiro Shirai; Ryoga Hamura; Takashi Horiuchi; Jungo Yasuda; Hironori Shiozaki; Takeshi Gocho; Hioaki Shiba; Toru Ikegami
Journal:  Ann Gastroenterol Surg       Date:  2020-08-06

3.  Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT.

Authors:  Ying Jia; Yufei Xing; Meitian Yang
Journal:  J Oncol       Date:  2021-08-11       Impact factor: 4.375

4.  Risk factors for postoperative portal vein thrombosis in patients with hepatitis B liver cancer and its impact on mortality-a retrospective study.

Authors:  Zhongshan Yu; Yizhi Zhou; Ya Li; Long Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

5.  Clinical Effect of Iodine-125 Seed Implantation in Patients with Primary Liver Cancer and Its Effect on Th1/Th2 Cells in Peripheral Blood.

Authors:  Xiaoyan Chen; Fan Zhu; Bin Wang; Yu Zhou; Hao Xiong; Tao Fan; Wenjie Ke
Journal:  J Oncol       Date:  2021-07-29       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.